ClinicalTrials.gov
public full text
Public Domain
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
hepatocellular-carcinomahepatocellular-carcinoma-hccimmunotherapyliver-cancermetastatic-liver-cancer
Open-label, dose escalation, multi-center, Phase I / II study to assess the safety of an autologous T-cell product (ET140203) in adult subjects with Alpha-fetoprotein (AFP)-positive/Human Leukocyte Antigen (HLA) A-2-positive advanced hepatocellular carcinoma (HCC).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma#892263
- Improving the Use of Immunotherapy to Treat Liver Cancer#471451
- Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells#143563
- Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.#1102806
- A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs#1047982
Record · ID 1244843
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive